Abstract:Urolithin A (UroA), a dietary phytochemical, is produced by gut bacteria from fruits rich in natural polyphenols ellagitannins (ETs). The efficiency of ETs metabolism to UroA in humans depends on gut microbiota. UroA has shown a variety of pharmacological activities. In this study we investigated the effects of UroA on atherosclerotic lesion development and stability. Apolipoprotein E-deficient (ApoE-/-) mice were fed a high-fat and high-cholesterol diet for 3 months to establish atherosclerosis model. Meanwhile the mice were administered UroA (50 mgkg-1d-1, i.g.). We showed that UroA administration significantly decreased diet-induced atherosclerotic lesions in brachiocephalic arteries, macrophage content in plaques, expression of endothelial adhesion molecules, intraplaque hemorrhage and size of necrotic core, while increased the expression of smooth muscle actin and the thickness of fibrous cap, implying features of plaque stabilization. The underlying mechanisms were elucidated using TNF-alpha-stimulated human endothelial cells. Pretreatment with UroA (10, 25, 50 mu M) dose-dependently inhibited TNF-alpha-induced endothelial cell activation and monocyte adhesion. However, the anti-inflammatory effects of UroA in TNF-alpha-stimulated human umbilical vein endothelial cells (HUVECs) were independent of NF-kappa B p65 pathway. We conducted RNA-sequencing profiling analysis to identify the differential expression of genes (DEGs) associated with vascular function, inflammatory responses, cell adhesion and thrombosis in UroA-pretreated HUVECs. Human disease enrichment analysis revealed that the DEGs were significantly correlated with cardiovascular diseases. We demonstrated that UroA pretreatment mitigated endothelial inflammation by promoting NO production and decreasing YAP/TAZ protein expression and TEAD transcriptional activity in TNF-alpha-stimulated HUVECs. On the other hand, we found that UroA administration modulated the transcription and cleavage of lipogenic transcription factors SREBP1/2 in the liver to ameliorate cholesterol metabolism in ApoE-/- mice. This study provides an experimental basis for new dietary therapeutic option to prevent atherosclerosis.

Exogenous supplement of N-acetylneuraminic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice.

The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-κB in ApoE-deficient mice.

Ganoderic Acid A Ameliorates Non-Alcoholic Streatohepatitis (NASH) Induced by High-Fat High-Cholesterol Diet in Mice

Dataset on Inflammatory Proteins Expressions and Sialic Acid Levels in Apolipoprotein E-Deficient Mice with Administration of N-Acetylneuraminic Acid And/Or Quercetin

N-acetylcysteine attenuates atherosclerosis progression in aging LDL receptor deficient mice with preserved M2 macrophages and increased CD146

Xiaoyaosan Prevents Atherosclerotic Vulnerable Plaque Formation Through Heat Shock Protein/glucocorticoid Receptor Axis-Mediated Mechanism.

Panax Notogingseng Saponins Suppress Rage/Mapk Signaling and Nf-Kappab Activation in Apolipoprotein-E-Deficient Atherosclerosis-Prone Mice

Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model.

N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial Function

Choline and Trimethylamine N-oxide Supplementation in Normal Chow Diet and Western Diet Promotes the Development of Atherosclerosis in Apoe -/- Mice Through Different Mechanisms.

Ag1296 Enhances Plaque Stability Via Inhibiting Inflammatory Responses and Decreasing Mmp-2 and Mmp-9 Expression in Apoe-/- Mice

Oral nanoparticles containing naringenin suppress atherosclerotic progression by targeting delivery to plaque macrophages

Rhamnan Sulfate Reduces Atherosclerotic Plaque Formation and Vascular Inflammation

Protective Role of N6/n3 PUFA Supplementation with Varying DHA/EPA Ratios Against Atherosclerosis in Mice

Naringenin promotes cell autophagy to improve high-fat-diet-induced atherosclerosis in ApoE-/- mice

N‐acetyl cysteine prevents ambient fine particulate matter‐potentiated atherosclerosis via inhibition of reactive oxygen species‐induced oxidized low density lipoprotein elevation and decreased circulating endothelial progenitor cell

Adrenomedullin ameliorates the development of atherosclerosis in apoE−/− mice

Phagocytosis of polymeric nanoparticles aided activation of macrophages to increase atherosclerotic plaques in ApoE−/− mice

Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice

Urolithin A Promotes Atherosclerotic Plaque Stability by Limiting Inflammation and Hypercholesteremia in Apolipoprotein E–deficient Mice

Study on the Mechanism of Improving Mice with Atherosclerosis Using Dendrocrepine